Skip to Main Content

Paper Details

Gut OncoMicrobiome Signatures (GOMS) as next-generation biomarkers for cancer immunotherapy.
Nat Rev Clin Oncol
21
2023
GOMS, cancer, chronic inflammatory disorders, intestinal dysbiosis, patient, patients
Author NameAffiliation
Jennifer A WargoThe University of Texas MD Anderson Cancer Center
Jennifer A WargoThe University of Texas MD Anderson Cancer Center
Jennifer A WargoMD Anderson Cancer Center
Nicola SegataUniversity of Trento
Nicola SegataEuropean Institute of Oncology IRCCS
  • 1 - 5

Datasets

Release 1.2